Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-kinase/Akt pathway

Journal of Virology

Volumn 74, Issue 22, 2000, Pages 10838-10845

  Swart, R ^a   Ruf, I K ^a   Sample, J ^a   Longnecker, R ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; MEMBRANE PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; VIRUS PROTEIN;

ARTICLE; BURKITT LYMPHOMA; CANCER CELL; CELL SURVIVAL; CELL TRANSFORMATION; CROSS LINKING; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; LYMPHOCYTE; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; B-LYMPHOCYTES; BURKITT LYMPHOMA; CELL LINE, TRANSFORMED; GENE EXPRESSION REGULATION; HERPESVIRUS 4, HUMAN; HUMANS; MICE; MICE, SCID; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; VIRAL MATRIX PROTEINS;

EID: 0033761806     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.22.10838-10845.2000     Document Type: Article

References (70)

1. Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase
2. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase B alpha
3. The dynamics of protein kinase B regulation during B cell antigen receptor engagement
4. Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3
5. Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas
6. A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region
7. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor
8. An Epstein-Barr virus transformation-associated membrane protein interacts with src family tyrosine kinases
9. Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals
10. New nomenclature for the Reth motif (or ARH1/TAM/ARAM/YXXL)
11. Regulation of cell death protease caspase-9 by phosphorylation
12. A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1
13. Expression of Epstein-Barr virus BamHI-A rightward transcripts in latently infected B cells from peripheral blood
14. Protein kinase B (c-Akt): A multifunctional mediator of phosphatidylinositol 3-kinase activation
15. Syk and Bruton's tyrosine kinase are required for B cell antigen receptor-mediated activation of the kinase Akt
16. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
17. Detection of the latent form of Epstein-Barr virus DNA in the peripheral blood of healthy individuals
18. The complexity of signaling pathways activated by the BCR
19. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase
20. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt
21. Mechanisms and consequences of activation of protein kinase B/Akt
22. CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr virus-encoded LMP1: Involvement of TRAF3 as a common mediator
23. Akt, a target of phosphatidylinositol 3-kinase, inhibits apoptosis in a differentiating neuronal cell line
24. Identification of latent membrane protein 2A (LMP2A) domains essential for the LMP2A dominant-negative effect on B-lymphocyte surface immunoglobulin signal transduction
25. The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction
26. Tyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein-Barr virus latency
27. Membrane Ig cross-linking regulates phosphatidylinositol 3-kinase in B lymphocytes
28. The B cell antigen receptor activates the Akt (protein kinase B)/glycogen synthase kinase-3 signaling pathway via phosphatidylinositol 3-kinase
29. Induction of bcl-2 expression in Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death
30. The Epstein-Barr virus (EBV) latent membrane protein 2A (LMP2A) PY motif recruits WW domain-containing ubiquitin-protein ligases
31. The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-κB
32. Macrophage colony-stimulating factor promotes cell survival through Akt/protein kinase B
33. Akt/protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria
34. Epstein-Barr virus and its replication
35. Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt's lymphoma cell line Akata
36. Epstein-Barr virus contributes to the malignant phenotype and to apoptosis resistance in Burkitt's lymphoma cell line Akata
37. Cross-linking of B cell antigen receptor-related structure of pre-B cell lines induces tyrosine phosphorylation of p85 and p110 subunits and activation of phosphatidylinositol 3-kinase
38. The tyrosine kinases Syk and Lyn exert opposing effects on the activation of protein kinase Akt/PKB in B lymphocytes
39. Epstein-Barr pathogenesis
40. Epstein-Barr virus latent membrane protein 2A has no growth-altering effects when expressed in differentiating epithelia
41. Molecular biology of Epstein-Barr virus
42. An Epstein-Barr virus protein associated with cell growth transformation interacts with a tyrosine kinase
43. A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1
44. Deletion of DNA encoding the first five transmembrane domains of Epstein-Barr virus latent membrane proteins 2A and 2B
45. Functions of SH2 and SH3 domains
46. Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases
47. An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking
48. Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes
49. Bad can act as a key regulator of T cell apoptosis and T cell development
50. Midkine inhibits caspase-dependent apoptosis via the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase in cultured neurons
51. p120cbl is a major substrate of tyrosine phosphorylation upon B cell antigen receptor stimulation and interacts in vivo with Fyn and Syk tyrosine kinases, Grb2 and Shc adaptors, and the p85 subunit of phosphatidylinositol 3-kinase
52. Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-kinase/Akt cell survival pathway
53. Tumor necrosis factor induces phosphorylation and translocation of BAD through a phosphatidylinositide-3-OH kinase-dependent pathway
54. Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase
55. Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes
56. Transcription factors of the NFAT family: Regulation and function
57. Antigen receptor tail clue
58. Epstein-Barr virus
59. Epstein-Barr virus small RNAs potentiate tumorigenicity of Burkitt lymphoma cells independently of an effect on apoptosis
60. Epstein-Barr virus regulates c-MYC, apoptosis, and tumorigenicity in Burkitt lymphoma
61. Two related Epstein-Barr virus membrane proteins are encoded by separate genes
62. Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates
63. Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: Malignant phenotypes of BL cells are dependent on EBV
64. Epstein-Barr virus lacking latent membrane protein 2 immortalizes B cells with efficiency indistinguishable from that of wild-type virus
65. Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: Amplification of AKT1 in a primary human gastric adenocarcinoma
66. Thymic lymphoma induction by the AKT8 murine retrovirus
67. An Epstein-Barr virus-producer line Akata: Establishment of the cell line and analysis of viral DNA
68. Epstein-Barr virus (EBV) in endemic Burkitt's lymphoma: Molecular analysis of primary tumor tissue
69. Epstein-Barr virus latency in blood mononuclear cells: Analysis of viral gene transcription during primary infection and in the carrier state
70. Essential role for protein kinase B (PKB) in insulin-induced glycogen synthase kinase 3 inactivation. Characterization of dominant-negative mutant of PKB